Per M. Almqvist
Corporate Officer/Principal chez Karolinska Institutet
Postes actifs de Per M. Almqvist
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | 13/08/2009 | - |
Historique de carrière de Per M. Almqvist
Anciens postes connus de Per M. Almqvist
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Bok Holding A/S
 Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Directeur Technique/Scientifique/R&D | - | - |
Statistiques
Internationale
| Danemark | 2 |
| Suède | 2 |
Opérationnelle
| Chief Tech/Sci/R&D Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Bok Holding A/S
Bok Holding A/S BiotechnologyHealth Technology Bok Holding A/S is a holding company that operates as a biotechnology company that researches and develops cancer treatment solutions. It develops the ZAS platform technology which efficiently enhances the effect of current anti-cancer drugs and reduces toxicity. The firm employs molecular techniques commonly known as molecular breeding or directed enzyme evolution which can activate anti-cancer drugs. The company was founded by Zoran Gojkovic on November 22, 2001 and is headquartered in Gentofte, Denmark. | Health Technology |
- Bourse
- Insiders
- Per M. Almqvist
- Expérience
